ARID4B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.245560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.790400E-01
Normal-vs-Stage2
1.286040E-01
Normal-vs-Stage3
1.239970E-01
Normal-vs-Stage4
7.865600E-01
Stage1-vs-Stage2
4.779000E-01
Stage1-vs-Stage3
7.651700E-02
Stage1-vs-Stage4
6.284800E-01
Stage2-vs-Stage3
1.687030E-01
Stage2-vs-Stage4
2.346400E-01
Stage3-vs-Stage4
7.832200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.067010E-01
Normal-vs-AfricanAmerican
7.686000E-01
Normal-vs-Asian
2.169600E-01
Caucasian-vs-AfricanAmerican
8.949500E-02
Caucasian-vs-Asian
8.226600E-01
AfricanAmerican-vs-Asian
1.526630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.406600E-01
Normal-vs-Female
1.293220E-01
Male-vs-Female
8.730400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.784400E-01
Normal-vs-Age(41-60Yrs)
3.042800E-01
Normal-vs-Age(61-80Yrs)
9.664000E-02
Normal-vs-Age(81-100Yrs)
6.254300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.844600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.880000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.949200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.244200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.086100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.256600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.001600E-01
Normal-vs-Daily Drinker
2.636000E-02
Normal-vs-Weekly Drinker
1.993040E-01
Normal-vs-Occasional Drinker
4.864200E-01
Normal-vs-Social Drinker
2.807600E-01
Non Drinker-vs-Daily Drinker
1.192760E-01
Non Drinker-vs-Weekly Drinker
8.540600E-01
Non Drinker-vs-Occasional Drinker
7.073700E-02
Non Drinker-vs-Social Drinker
4.762000E-01
Daily Drinker-vs-Weekly Drinker
3.921000E-01
Daily Drinker-vs-Occasional Drinker
7.584900E-03
Daily Drinker-vs-Social Drinker
8.312400E-02
Weekly Drinker-vs-Occasional Drinker
1.715840E-01
Weekly Drinker-vs-Social Drinker
5.312200E-01
Occasional Drinker-vs-Social Drinker
4.308200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.066200E-02
Normal-vs-Grade 2
2.023400E-03
Normal-vs-Grade 3
2.460100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.151200E-01
Grade 1-vs-Grade 3
3.069800E-01
Grade 1-vs-Grade 4
3.066200E-02
Grade 2-vs-Grade 3
4.829600E-01
Grade 2-vs-Grade 4
2.023400E-03
Grade 3-vs-Grade 4
2.460100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.130100E-02
Normal-vs-NonDiabetic
7.805900E-02
Diabetic-vs-NonDiabetic
3.767600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.341800E-01
Normal-vs-NoPancreatitis
9.503800E-02
Pancreatitis-vs-NoPancreatitis
1.781220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.104400E-01
Normal-vs-N1
1.135770E-01
N0-vs-N1
5.303800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.742800E-01
Normal-vs-TP53-NonMutant
3.358400E-01
TP53-Mutant-vs-TP53-NonMutant
9.884400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
